BioSpace News Archive

Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner

Sofinnova Partners announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.

January 4, 2024
·
3 min read
BioCapital

Advances in Liquid Biopsy That Are Poised to Improve Cancer Care Highlighted in Special Issue of ADLM’s Clinical Chemistry Journal

The Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) Clinical Chemistry journal released a special issue today titled “Cancer: Biology and Diagnostics,” which presents a wide range of discoveries with the potential to improve cancer diagnosis and treatment.

January 4, 2024
·
4 min read
BioForest

Lapatinib Increases Overall Survival in Metastatic Breast Cancer Patients With HER2-Positive Circulating Tumor Cells

A new study shows that lapatinib, a drug used for the treatment of metastatic HER2-positive cancer, is associated with improved overall survival in patients with initially HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells (CTCs).

January 4, 2024
·
4 min read
Drug Development

Faraday Pharmaceuticals Announces Agreement with FDA on Interim Analysis of Phase 3 IOCYTE AMI-3 Trial Data and EU Notice of Intention to Grant Patent

Faraday Pharmaceuticals, Inc. today announced its agreement with the Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) amendment, enabling the company to expedite its planned Phase 3 study interim analysis.

January 4, 2024
·
4 min read
Job Trends

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

Galapagos NV announced that it has entered into a strategic collaboration agreement with Thermo Fisher Scientific, Inc. for the decentralized manufacturing of Galapagos’ point-of-care CAR-T product candidate in the San Francisco area.

January 4, 2024
·
5 min read
Genetown

C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals

C4 Therapeutics, Inc. announced the closing of the previously announced $25 million stock purchase agreement with a wholly-owned subsidiary of Betta Pharmaceuticals Co. Ltd, a leading pharmaceutical company focusing on the development of innovative oncology therapies in China.

January 4, 2024
·
3 min read
Drug Development

Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy

Applied Therapeutics, Inc. announced the topline results of the ARISE-HF Phase 3 trial of AT-001 in patients with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.

January 4, 2024
·
9 min read
Business

Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024

Illumina, Inc. announced that it will issue results for the fourth quarter and full year 2023 following the close of market on Thursday, February 8, 2024.

January 4, 2024
·
1 min read
Pharm Country

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jan 04, 2024

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to one new employee.

January 4, 2024
·
3 min read
BioMidwest

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

Axogen, Inc. announced that President and Chief Executive Officer Karen Zaderej plans to retire from the Company by January 2025.

January 4, 2024
·
7 min read